Medicine by Design expands Entrepreneur-in-Residence program to drive research translation and commercialization
Two new advisors with decades of industry experience join the program as advisors.
HDAX Therapeutics receives $25,000 in research funding at Medicine by Design pitch competition
Thanks to this team’s effective storytelling, sound science and clear pathway to translation, HDAX was chosen by the judges to receive research funding.
Pivotal Experiment Fund to accelerate Medicine by Design-funded research toward impact
Medicine by Design's $4-million Pivotal Experiment Fund aims to bridge one of the critical gaps in the “valley of death” between a research discovery and a translatable therapy.